|
WDR33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.999200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.414500E-04 |
| Normal-vs-Stage2 |
1.563180E-01 |
| Normal-vs-Stage3 |
1.383590E-01 |
| Normal-vs-Stage4 |
3.294000E-01 |
| Stage1-vs-Stage2 |
5.029800E-01 |
| Stage1-vs-Stage3 |
5.495000E-01 |
| Stage1-vs-Stage4 |
7.377600E-01 |
| Stage2-vs-Stage3 |
8.995400E-01 |
| Stage2-vs-Stage4 |
8.767400E-01 |
| Stage3-vs-Stage4 |
9.614000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.203470E-03 |
| Normal-vs-AfricanAmerican |
1.837560E-02 |
| Normal-vs-Asian |
6.058600E-01 |
| Caucasian-vs-AfricanAmerican |
9.356400E-01 |
| Caucasian-vs-Asian |
7.062000E-01 |
| AfricanAmerican-vs-Asian |
7.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03129999999385E-05 |
| Normal-vs-Female |
9.202400E-01 |
| Male-vs-Female |
1.751640E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.721000E-03 |
| Normal-vs-Extreme_Weight |
3.796100E-04 |
| Normal-vs-Obese |
5.156400E-02 |
| Normal-vs-Extreme_Obese |
2.204200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.001000E-01 |
| Normal_Weight-vs-Obese |
3.500600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.418600E-01 |
| Extreme_Weight-vs-Obese |
1.555180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.137200E-01 |
| Obese-vs-Extreme_Obese |
8.223600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.599000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.862400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.53320000000545E-05 |
| Normal-vs-Age(81-100Yrs) |
3.734200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.090000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.020000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.809200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.467900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.345800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.663200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.338900E-03 |
| Normal-VS-Type2 PRCC |
7.372000E-04 |
| Normal-VS-KIRP CIMP |
6.502200E-01 |
| Normal-VS-Unclassified PRCC |
1.180840E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.979400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.934000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.146400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.733200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.403200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.652800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.564740E-04 |
| Normal-vs-N1 |
8.920200E-01 |
| Normal-vs-N2 |
8.383900E-03 |
| N0-vs-N1 |
3.289600E-02 |
| N0-vs-N2 |
1.233750E-02 |
| N1-vs-N2 |
2.439800E-01 |
|
|
